Skip to main content

Table 3 Combined effects of CRP, PRS and the risk of Psoriasis

From: The role of C-reactive protein and genetic predisposition in the risk of psoriasis: results from a national prospective cohort

Outcomes

PRS levels (HR, 95% CI)

 

RERI ‡

P for

interaction §

Low PRS

Moderate PRS

High PRS

 

Moderate PRS

High PRS

CRP

       

 < 2 mg/dL

1.00

1.16 (1.04, 1.29)

1.68 (1.52, 1.86)

   

0.0028

 ≥ 2 mg/dL

1.04 (0.91, 1.18)

1.55 (1.38, 1.74)

2.24 (2.01, 2.49)

 

0.37 (0.17, 0.56)

0.51 (0.30, 0.73)

 
  1. Adjustment for age, sex, ethnicity, annual income, smoking status, drinking status, Body mass index (BMI), diabetes mellitus, dyslipidemia, and hypertension history
  2. HR, hazard ratio; CI, confidence interval; CRP, C-reactive protein; PRS: polygenic risk score; RERI, relative excess risk due to interaction
  3. ‡: The estimates of RERI were calculated based on the reference group with low CRP and low PRS
  4. §: Likelihood tests was applied to test the significance of interaction term by comparing the model with and without the interaction term